Outcome of Dopamine Agonist Therapy Withdrawal in Children with Prolactinomas

Conclusions: Less than half of our patients were eligible for DA treatment withdrawal and less than one fourth achieved remission of hyperprolactinemia following cessation of therapy. This suggests that the overall recurrence rate of prolactinomas in pediatric patients may be higher than has been reported in adults.
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research